The Covax coronavirus vaccine sharing scheme has allocated at least 330 million doses of Covid-19 vaccines for poorer countries in the first half of 2021, the GAVI vaccine alliance said on Wednesday.
The allocation includes an initial 240 million doses of the AstraZeneca-Oxford Covid-19 vaccine made by the Serum Institute of India, an additional 96 million doses of the same shot made by AstraZeneca, plus 1.2 million doses of Pfizer -BioNTech'S Covid-19 vaccine.
Publishing an interim distribution plan, the COVAX Facility, which is co-led by GAVI, the World Health Organization, the Coalition for Epidemic Preparedness Innovations and the U.N. Children's Fund, said doses would cover an average of 3.3% of total populations of 145 participating countries.
The facility, which is co-led by GAVI, the World Health Organization, the Coalition for Epidemic Preparedness Innovations and the UN Children's Fund, said its interim distribution forecast would cover an average of 3.3% of total populations of 145 participating countries.
Covax said in a statement that the allocations would be subject to various caveats, including WHO emergency listing and countries' readiness and acceptance.